Jeffrey Stein - 23 May 2016 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Reporting relationship: President & CEO, Director
Issuer ticker: CDTX
Reported as of: 23 May 2016
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jan 2026, 20:12:25 UTC
Next SEC filing: 16 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Shane Ward, Attorney-in-Fact

Key filing fact

Jeffrey Stein filed Form 4 for Cidara Therapeutics, Inc. (CDTX) on 07 Jan 2026.

Key facts

This page summarizes Jeffrey Stein's Form 4 filing for Cidara Therapeutics, Inc. (CDTX).
12 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jan 2026, 20:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001478831 Primary reporting owner

Stein Jeffrey

Relationship: President & CEO, Director
Address: 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO
Signature: /s/ Shane Ward, Attorney-in-Fact
Signature date: 07 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDTX transaction

Common Stock

Other

Transaction value
Shares: -270
Change %: -2.6%
Price
Shares after: 10,025
Date: 23 May 2016
Ownership: Direct
Footnotes: F1, F2

CDTX transaction

Common Stock

Other

Transaction value: $99,975
Shares: -645
Change %: -6.4%
Price: $155.00
Shares after: 9,380
Date: 31 Mar 2017
Ownership: Direct
Footnotes: F2, F3

CDTX transaction

Common Stock

Purchase

Transaction value: $99,975
Shares: +645
Change %: +0.99%
Price: $155.00^*
Shares after: 65,754
Date: 31 Mar 2017
Ownership: By trust
Footnotes: F2, F3

CDTX transaction

Common Stock

Other

Transaction value: $89,211
Shares: -750
Change %: -8%
Price: $118.95
Shares after: 8,630
Date: 05 Jun 2017
Ownership: Direct
Footnotes: F2, F4

CDTX transaction

Common Stock

Purchase

Transaction value: $89,211
Shares: +750
Change %: +1.1%
Price: $118.95^*
Shares after: 66,504
Date: 05 Jun 2017
Ownership: By trust
Footnotes: F2, F4

CDTX transaction

Common Stock

Other

Transaction value: $49,839
Shares: -367
Change %: -4.3%
Price: $135.80
Shares after: 8,263
Date: 12 Sep 2017
Ownership: Direct
Footnotes: F2, F5

CDTX transaction

Common Stock

Purchase

Transaction value: $49,839
Shares: +367
Change %: +0.55%
Price: $135.80^*
Shares after: 66,871
Date: 12 Sep 2017
Ownership: By trust
Footnotes: F2, F5

CDTX transaction

Common Stock

Other

Transaction value: $100,015
Shares: -2,500
Change %: -30%
Price: $40.01
Shares after: 5,763
Date: 10 Nov 2020
Ownership: Direct
Footnotes: F2, F6

CDTX transaction

Common Stock

Purchase

Transaction value: $100,015
Shares: +2,500
Change %: +3.7%
Price: $40.01^*
Shares after: 69,371
Date: 10 Nov 2020
Ownership: By trust
Footnotes: F2, F6

CDTX transaction

Common Stock

Other

Transaction value: $0
Shares: -658
Change %: -31%
Price: $0.000000
Shares after: 1,442
Date: 10 Dec 2020
Ownership: By son
Footnotes: F2, F7

CDTX transaction

Common Stock

Gift

Transaction value: $0
Shares: -1,873
Change %: -2.7%
Price: $0.000000
Shares after: 67,498
Date: 31 Dec 2021
Ownership: By trust
Footnotes: F2, F8

CDTX transaction

Common Stock

Gift

Transaction value: $0
Shares: +937
Change %: +65%
Price: $0.000000
Shares after: 2,379
Date: 31 Dec 2021
Ownership: By son
Footnotes: F2, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Form 4 originally filed on May 23, 2016 erroneously overstated the Amount of Securities Beneficially Owned by Reporting Person.

Footnote F2

The number of securities and price reported herein have been adjusted to reflect the 1-for-20 reverse stock split effected by the Issuer on April 24, 2024.

Footnote F3

Form 4 originally filed on April 4, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.

Footnote F4

Form 4 originally filed on June 7, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.

Footnote F5

Form 4 originally filed on September 12, 2017 erroneously reported the securities as purchased by Reporting Person rather than by trust.

Footnote F6

Form 4 originally filed on November 10, 2020 erroneously reported the securities as purchased by Reporting Person rather than by trust.

Footnote F7

Form 4 originally filed on March 19, 2021 erroneously reported a 26,300 share gift as a holding rather than a transaction and further overstated the holdings received by son by 13,150 shares.

Footnote F8

This transaction involved a gift of securities by the Reporting Person to his sons, one of which is economically dependent on the Reporting Person. The Reporting Person disclaims beneficial ownership of the shares held by his independent son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his independent son's shares for purposes of Section 16 or for any other purpose.